Download PDF
Semin Thromb Hemost 2002; 28(6): 545-554
DOI: 10.1055/s-2002-36699
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Increased Expression of Plasminogen Activator Inhibitor-1 with Fibrin Deposition in a Murine Model of Aging, "Klotho" Mouse

Kyosuke Takeshita1 , Koji Yamamoto1 , Masafumi Ito2 , Takahisa Kondo1 , Tadashi Matsushita1 , Makoto Hirai1 , Tetsuhito Kojima3 , Masahiko Nishimura4 , Yoichi Nabeshima5 , David J. Loskutoff6 , Hidehiko Saito7 , Toyoaki Murohara1
  • 1First Department of Internal Medicine, Nagoya University School of Medicine, Nagoya
  • 2Department of Pathology, Nagoya University Hospital, Nagoya
  • 3Department of Medical Technology, Nagoya University School of Health Sciences, Nagoya
  • 4Institute for Laboratory Animal Research, Nagoya University School of Medicine, Nagoya
  • 5Department of Pathology and Tumor Biology, Kyoto University Graduate School of Medicine, Kyoto, Japan
  • 6Department of Vascular Biology (VB-3), The Scripps Research Institute, La Jolla, California
  • 7Nagoya National Hospital, Nagoya, Japan
Further Information

Publication History

Publication Date:
21 January 2003 (online)

    Permissions and Reprints

ABSTRACT

Although aging accompanies specific pathological changes, including thrombosis and organ sclerosis, the underlying mechanisms of these processes remain to be elucidated. In the present study, we analyzed the gene expression of plasminogen activator inhibitor-1 (PAI-1), a key molecule in the development of thrombosis, in a murine model of aging, klotho mutant (kl/kl) mice. Active PAI-1 antigen in plasma and PAI-1 mRNA in several tissues were strikingly elevated in kl/kl mice as compared with wild-type mice. This increased PAI-1 expression was age dependent and linked to the development of ectopic calcification and glomerular fibrin deposition in the kidneys. In situ hybridization analysis of kl/kl mice demonstrated that strong signals for PAI-1 mRNA were localized in renal tubular epithelial cells, cardiomyocytes, adrenal medullar cells, and smooth muscle and endothelial cells in Mönckeberg's arteriosclerotic vessels. Renal glomerular fibrin deposition, as evaluated immunohistochemically, was occasionally observed only in kl/kl mice, and the number of fibrin-positive glomeruli increased as the kl/kl mice aged. These observations suggest that in the process of aging the PAI-1 gene expression is increased, contributing to the development of thrombosis.

KEYWORD

Thrombosis - fibrinolysis - proteolysis - gene expression - sclerosis

REFERENCES

  • 1 Tracy R P, Bovill E G. Thrombosis and cardiovascular risk in the elderly.  Arch Pathol Lab Med . 1992;  116 1307-1312
    PubMedGoogle Scholar
  • 2 Sagripanti A, Carpi A. Natural anticoagulants, aging, and thromboembolism.  Exp Gerontol . 1998;  33 891-896
    CrossrefPubMedGoogle Scholar
  • 3 Kiechl S, Willeit J. The natural course of atherosclerosis. Part II: Vascular remodeling.  Arterioscler Thromb Vasc Biol . 1999;  19 1491-1498
    CrossrefPubMedGoogle Scholar
  • 4 Balleisen L, Bailey J, Epping P H, Schulte H, van de Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population. I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause.  Thromb Haemost . 1985;  54 475-479
    PubMedGoogle Scholar
  • 5 Kurachi S, Deyashiki Y, Takeshita J, Kurachi K. Genetic mechanisms of age regulation of human blood coagulation factor IX.  Science . 1999;  285 739-743
    CrossrefPubMedGoogle Scholar
  • 6 Köster T, Rosendaal F R, Reitsma P H, van der Velden A P, Vandenbroucke J P. Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms-The Leiden Thrombophilia Study (LETS).  Thromb Haemost . 1994;  71 719-722
    PubMedGoogle Scholar
  • 7 Woodward M, Lowe G DO, Rumley A. Epidemiology of coagulation factors, inhibitors and activation markers: The third Glasgow MONICA survey II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease.  Br J Haematol . 1997;  97 785-797
    CrossrefPubMedGoogle Scholar
  • 8 Aillaud M F, Pignol F, Alessi M C. Increase in plasma concentration of plasminogen activator inhibitor, fibrinogen, von Willebrand factor, factor VIII:C and in erythrocyte sedimentation rate with age.  Thromb Haemost . 1986;  55 330-332
    PubMedGoogle Scholar
  • 9 Hashimoto Y, Kobayashi A, Yamazaki N. Relationship between age and plasma t-PA, PA-inhibitor, and PA activity.  Thromb Res . 1987;  46 625-633
    CrossrefPubMedGoogle Scholar
  • 10 Loskutoff D J, Sawdey M, Mimuro J. Type 1 plasminogen activator inhibitor.  Progr Hemost Thromb . 1988;  10 87-115
    PubMedGoogle Scholar
  • 11 Yamamoto K, Saito H. A pathological role of increased expression of plasminogen activator inhibitor-1 in human or animal disorders.  Int J Hematol . 1998;  68 371-385
    CrossrefPubMedGoogle Scholar
  • 12 Kohler H P, Grant P J. Plasminogen activator inhibitor type 1 and coronary artery disease.  N Engl J Med . 2000;  342 1792-1801
    CrossrefPubMedGoogle Scholar
  • 13 Hamsten A, Wiman B, de Faire U, Blombäck M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.  N Engl J Med . 1985;  313 1557-1563
    CrossrefPubMedGoogle Scholar
  • 14 Hamsten A, de Faire U, Walldius G. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.  Lancet . 1987;  2 3-9
    PubMedGoogle Scholar
  • 15 Jørgensen M, Bonnevie-Nielsen V. Increased concentration of the fast-acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis.  Br J Haematol . 1987;  65 175-180
    PubMedGoogle Scholar
  • 16 Pralong G, Calandra T, Glauser M-P. Plasminogen activator inhibitor 1: a new prognostic marker in septic shock.  Thromb Haemost . 1989;  61 459-462
    PubMedGoogle Scholar
  • 17 Schneiderman J, Sawdey M S, Keeton M R. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.  Proc Natl Acad Sci USA . 1992;  89 6998-7002
    CrossrefPubMedGoogle Scholar
  • 18 Lupu F, Bergonzelli G E, Heim D A. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries.  Arterioscler Thromb . 1993;  13 1090-1100
    CrossrefPubMedGoogle Scholar
  • 19 Eitzman D T, Westrick R J, Xu Z, Tyson J, Ginsburg D. Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery.  Blood . 2000;  96 4212-4215
    PubMedGoogle Scholar
  • 20 Kuro-o M, Matsumura Y, Aizawa H. Mutation of the mouse klotho gene leads to a syndrome resembling ageing.  Nature . 1997;  390 45-51
    CrossrefPubMedGoogle Scholar
  • 21 Shiraki-Iida T, Aizawa H, Matsumura Y. Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein.  FEBS Lett . 1998;  424 6-10
    CrossrefPubMedGoogle Scholar
  • 22 Saito Y, Yamagishi T, Nakamura T. Klotho protein protects against endothelial dysfunction.  Biochem Biophys Res Commun . 1998;  248 324-329
    CrossrefPubMedGoogle Scholar
  • 23 Moore K L, Andreoli S P, Esmon N L, Esmon C T, Bang N U. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro.  J Clin Invest . 1987;  79 124-130
    CrossrefPubMedGoogle Scholar
  • 24 Yamamoto K, Loskutoff D J. Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator.  J Clin Invest . 1996;  97 2440-2451
    CrossrefPubMedGoogle Scholar
  • 25 Schleef R R, Sinha M, Loskutoff D J. Immunoradiometric assay to measure the binding of a specific inhibitor to tissue-type plasminogen activator.  J Lab Clin Med . 1985;  106 408-415
    PubMedGoogle Scholar
  • 26 Gibson U EM, Heid C A, Williams P M. A novel method for real time quantitative RT-PCR.  Genome Res . 1996;  6 995-1001
    PubMedGoogle Scholar
  • 27 Yamamoto K, Loskutoff D J. The kidneys of mice with autoimmune disease acquire a hypofibrinolytic/procoagulant state that correlates with the development of glomerulonephritis and tissue microthrombosis.  Am J Pathol . 1997;  151 725-734
    PubMedGoogle Scholar
  • 28 Abrass C K, Adcox M J, Raugi G J. Aging-associated changes in renal extracellular matrix.  Am J Pathol . 1995;  146 742-752
    PubMedGoogle Scholar
  • 29 Moll S, Schifferli J A, Huarte J. LPS induces major changes in the extracellular proteolytic balance in the murine kidney.  Kidney Int . 1994;  45 500-508
    PubMedGoogle Scholar
  • 30 Sawdey M S, Loskutoff D J. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-α, and transforming growth factor-β.  J Clin Invest . 1991;  88 1346-1353
    CrossrefPubMedGoogle Scholar